CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company a broad patent (No. 9700655) that covers Ra Medical Systems’ DABRA™ catheter for cardiovascular disease treatment. The patent was granted on July 11, 2017, and assigned to Ra Medical Systems. The inventors include Ra Medical Systems Director of Research and Development, Dr. James Laudenslager, and CEO / CTO, Dean Irwin. DABRA recently received FDA market clearance and is now available in the U.S. and Europe.
DABRA will fundamentally change the way that arterial blockages are treated. It is a better, safer, faster and less-expensive option to other treatments that are currently on the market and is meeting an important unmet patient need.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly